Cormorant Asset Management, LLC Insider Trading $APLS Apellis Pharmaceuticals, Inc.

Get the latest insider transactions of Cormorant Asset Management, LLC. Cormorant Asset Management, LLC is 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Apellis Pharmaceuticals, Inc. ($APLS) and in Atea Pharmaceuticals, Inc. ($AVIR) and in Avidity Biosciences, Inc. ($RNA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Kezar Life Sciences, Inc. ($KZR) and in Prometheus Biosciences, Inc. ($RXDX) and in Rain Therapeutics Inc. ($RAIN) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in Olema Pharmaceuticals, Inc. ($OLMA) and in BioAtla, Inc. ($BCAB) and Director in Biomea Fusion, Inc. ($BMEA).